BioCentury | Feb 10, 2014
Financial News

Tiltan completes venture financing

Tiltan Pharma Ltd. , Jerusalem, Israel Business: Cancer Date completed: 2/5/14 Type: Venture financing Raised: $1.5 million WIR Staff cancer...
BioCentury | Nov 5, 2012
Company News

The Hebrew University of Jerusalem pharmaceuticals, other news

...includes infectious and inflammatory disease company Atox Bio Inc. (Ness Ziona, Israel) and cancer company Tiltan Pharma Ltd....
BioCentury | Nov 1, 2012
Financial News

Hebrew University tech transfer arm forms investment subsidiary

...includes infectious and inflammatory disease company Atox Bio Inc. (Ness Ziona, Israel) and cancer company Tiltan Pharma Ltd....
BioCentury | Feb 20, 2012
Clinical News

TL-118: Phase II started

...compare oral TL-118 once daily plus gemcitabine vs. gemcitabine alone in 80 newly diagnosed patients. Tiltan Pharma Ltd....
Items per page:
1 - 4 of 4
BioCentury | Feb 10, 2014
Financial News

Tiltan completes venture financing

Tiltan Pharma Ltd. , Jerusalem, Israel Business: Cancer Date completed: 2/5/14 Type: Venture financing Raised: $1.5 million WIR Staff cancer...
BioCentury | Nov 5, 2012
Company News

The Hebrew University of Jerusalem pharmaceuticals, other news

...includes infectious and inflammatory disease company Atox Bio Inc. (Ness Ziona, Israel) and cancer company Tiltan Pharma Ltd....
BioCentury | Nov 1, 2012
Financial News

Hebrew University tech transfer arm forms investment subsidiary

...includes infectious and inflammatory disease company Atox Bio Inc. (Ness Ziona, Israel) and cancer company Tiltan Pharma Ltd....
BioCentury | Feb 20, 2012
Clinical News

TL-118: Phase II started

...compare oral TL-118 once daily plus gemcitabine vs. gemcitabine alone in 80 newly diagnosed patients. Tiltan Pharma Ltd....
Items per page:
1 - 4 of 4